How can you patent genes?

Area of Science:

• Intellectual Property Law
• Biotechnology Law
• Genomic Science

Background:

• The patent system's traditional framework is ill-suited for the complexities of intellectual property in the information age.
• Patenting biological materials, particularly DNA sequences, presents unique challenges due to their dual nature as physical molecules and informational entities.

Purpose of the Study:

• To analyze the persistent ambiguities in legal procedures governing the patenting of DNA sequences.
• To identify the core reasons behind the difficulties in applying existing patent law to genetic material.

Main Methods:

• Legal analysis of patent law principles.
• Examination of the historical development of patent systems.
• Comparative analysis of 'bricks-and-mortar' versus information economies.

Main Results:

• The patent system was originally conceived for tangible, physical inventions, not intangible informational assets.
• DNA sequences function as both physical substances and carriers of genetic information, creating a conflict with patent law's traditional scope.
• This inherent conflict leads to a continued lack of clarity and procedural difficulties in DNA sequence patenting.

Conclusions:

• The fundamental incompatibility between the patent system's design and the nature of genetic information is the primary cause of ongoing legal uncertainty.
• Revisiting and potentially adapting patent law frameworks may be necessary to adequately address the patenting of DNA sequences and other biological information.